Avid Biosciences Shares Are Trading Higher After the Company Announced It Agreed to Be Acquired by GHO Capital Partners and Ampersand in a $1.1 Billion Transaction. Also, RBC Capital Raised Its Price Target on the Stock From $12 to $12.5.
Avid Biosciences Shares Are Trading Higher After the Company Announced It Agreed to Be Acquired by GHO Capital Partners and Ampersand in a $1.1 Billion Transaction. Also, RBC Capital Raised Its Price Target on the Stock From $12 to $12.5.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated